Nordic Capital Acquires Healthcare Analytics Company Arcadia
The Nordic acquisition marks an exit for earlier investors, such as healthcare specialist Peloton Equity, whose predecessor firm Ferrer Freeman acquired Arcadia in 2012. Other backers include drugmaker Merck's digital-health venture-capital arm and private-credit firm Vista Credit Partners.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Health Line
26 minutes ago
- Health Line
Does Medicare Cover Acupuncture for Neuropathy?
Original Medicare only covers acupuncture to treat chronic lower back pain. But some Part C plans might cover acupuncture for treating other pain conditions like neuropathy. Acupuncture, a holistic practice with a history spanning thousands of years, is thought to be effective for treating both acute and chronic pain, including neuropathy or nerve pain. In 2020, the Centers for Medicare & Medicaid Services (CMS) introduced new regulations concerning Medicare's coverage for acupuncture treatments. However, these new regulations do not extend to covering acupuncture for neuropathy treatment. Why does Medicare not pay for acupuncture for neuropathy? Original Medicare (parts A and B) only covers acupuncture when used to treat chronic lower back pain. The plan tends to cover medical care that is medically necessary and proven to be effective. Although neuropathic pain is common, and acupuncture does show some promise in treating it, more research is needed to confirm the treatment's effectiveness in this space. This means Original Medicare may consider acupuncture for neuropathy as experimental or without sufficient evidence for its effectiveness. How do I get Medicare to pay for acupuncture? You aren't likely to get acupuncture for neuropathy covered under Original Medicare. That said, you have the option of signing up for Medicare Advantage (Part C), which is an alternative to Original Medicare. Part C plans are managed by private insurers, and some Part C plans may offer benefits that Original Medicare does not offer. They may approve coverage for acupuncture for indications not covered by Original Medicare, including for neuropathy. Medicare Advantage Open Enrollment Medicare open enrollment occurs each year from October 15 through December 7. During this period, you may join, drop, or switch Original Medicare, Medicare Advantage, or Part D plans. You can find Part C plans available in your area by entering your zip code on Just remember, even if your plan approves coverage, you may need to see an acupuncture provider in your plan's network, depending on the type of plan you have. How many acupuncture visits does Medicare cover? Under Original Medicare, when you get acupuncture for chronic lower back pain, Medicare Part B covers 12 acupuncture sessions within 90 days and up to 20 sessions per year. If you show improvement during treatment, Part B may cover an additional eight sessions. However, this would not apply to acupuncture when needed for treating neuropathy. If you are enrolled in a Part C plan and your plan approves your acupuncture treatment for neuropathy, the number of sessions you can get covered will depend on your plan. How much would acupuncture for neuropathy cost under Medicare? Acupuncture for chronic lower back pain that falls under Part B will be covered once a person meets their annual deductible, which is $257 in 2025. After that, Part B will pay for 80% of the cost. If your Part C plan approves acupuncture for neuropathy, your coinsurance, deductible, and premium will depend on your plan. According to the Centers for Medicaid & Medicare (CMS), the average monthly premium for Part C plans is around $17 in 2025. In addition, to stay enrolled in a Part C plan, you still have to pay the Part B premium. That said, some Part C may cover your Part B premium. Does acupuncture get rid of neuropathy? Acupuncture involves inserting needles into pressure points to stimulate the nervous system, potentially releasing endorphins for natural pain relief and altering pain responses. Research suggests acupuncture could help treat peripheral neuropathy and neuropathic pain, and methods like electroacupuncture show promise in reducing nerve sensitivity and inflammation. Reviews have also found acupuncture beneficial for diabetic peripheral neuropathy, neuropathy from spinal cord injury, and chemotherapy-induced neuropathy, though more research is needed to verify the effectiveness. »Learn more: Acupuncture for Neuropathy Takeaway Acupuncture may be effective in treating both acute and chronic pain, including nerve pain or neuropathy. In 2020, the Centers for Medicare & Medicaid Services (CMS) implemented new rules regarding Medicare's coverage of acupuncture treatments. However, these regulations do not include coverage for acupuncture as a treatment for neuropathy. Currently, Original Medicare solely covers acupuncture for back pain. However, certain Part C plans may offer coverage for acupuncture to treat other conditions, such as neuropathy.
Bloomberg
31 minutes ago
- Bloomberg
Bally's Sells Interactive Casino Unit to Intralot in $3.2 Billion Deal
Bally's Corp. is selling its interactive casino business to Intralot SA in a deal that values the business at €2.7 billion (US $3.2 billion). The division, formally known as Gamesys, will be part of a combined company with about €1.1 billion of revenue, 60% of that from the UK, according to a statement Tuesday. Bally's Chief Executive Officer Robeson Reeves will become CEO of the new business.
Forbes
41 minutes ago
- Forbes
Glenfiddich Owners William Grant & Sons Acquire Famous Grouse
The iconic Scotch whisky brand - Scotland's bestselling whisky - has now been acquired by family ... More firm William Grant & Sons. Following a number of regulatory approvals including from the UK Competition & Markets Authority, Scotch whisky titans and family firm William Grant & Sons has officially acquired two well-known whisky brands—The Famous Grouse and Naked Malt. Though for months the acquisition was an open secret within the industry, it was officially announced today (July 1st) and marks a significant addition to the company's iconic stable of Scotch whisky brands and distilleries which includes names like Glenfiddich, Balvenie, Monkey Shoulder, and many more. The purchase sees the brands transferred from previous owners Edrington, who own the Macallan and Highland Park distilleries, amongst others. According to The Northern Scot, Edrington had announced the agreement last year in September, as the company wanting to focus further on 'ultra-premium spirits'. William Grant & Sons' addition of Famous Grouse and Naked Malt further strengthens its offering in the Scotch blends where Famous Grouse has long been a leader—it's the bestselling whisky in Scotland. Soren Hagh, the recently appointed chief executive of William Grant & Sons, expressed his enthusiasm for the acquisition in the official press announcement: 'I am delighted to complete this acquisition and welcome The Famous Grouse into our portfolio. It is a remarkable Scottish brand with rich history and a strong market position in a number of countries. Over the coming years, we will build on this strong foundation and work to evolve the brand into a true global icon. We also see a lot of potential in Naked Malt, which will be a great addition to our portfolio. Together, these brands perfectly complement our vision for growth, and we look forward to investing in their future and sharing their stories with whisky lovers around the world.' The deal concludes several months of negotiation and transition planning between William Grant & Sons and Edrington, the Glasgow-based company that had owned Famous Grouse since the 19th century. While Edrington has been shifting focus toward premium single malts like The Macallan and Highland Park, Famous Grouse had remained a key revenue generator in its portfolio. According to industry coverage the acquisition includes both the brands and their associated inventory (including spinoff brands such as Famous Grouse Smoky Black, Sherry Cask Finish, and others) are now fully under WG&S control, though exact production arrangements haven't been revealed. It's likely that existing contracts and bottling facilities will stay in place for now. First launched in 1896, Famous Grouse is the creation of grocer Matthew Gloag III from Perthshire and has been Scotland's bestselling whisky since 1980. It also holds a Royal Warrant, which was renewed by King Charles III in December 2024, and exports to over 100 countries. Naked Malt was first launched as the Naked Grouse in 2011 before becoming a standalone brand in 2017 and then renamed in 2021. This one is a blended malt whisky aged in first-fill sherry casks that's proven to be a particular hit in Asian markets. With the acquisition of both brands, William Grant & Sons strengthens its hand in the blended market - this is particularly interesting as so many other whisky companies, such as Edrington, focus on going premium these days. In any case, consumers won't see any significant changes for the moment with the shift in ownership, but it will certainly be interesting to see what comes next for such an iconic whisky brand like Famous Grouse.
